Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele Scarpa

Showing results (21-30 of 211) with videos related to

Pageof 22
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2026
TOGETHER-PsA and the Case for Precision Phenotyping in Psoriatic Arthritis Commentary on: "Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults with Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial"Francesco Caso, Luisa Costa, Raffaele Scarpa, et al.
Drugs & Aging|February 21, 2014
Managing moderate-to-severe psoriasis in the elderlyNicola Balato, Cataldo Patruno, Maddalena Napolitano, et al.
The Journal of Rheumatology|September 3, 2017
Psoriatic Disease 10 Years LaterRaffaele Scarpa, Francesco Caso, Luisa Costa, et al.
International Journal of Rheumatic Diseases|March 1, 2014
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanerceptLuisa Costa, Mariangela Atteno, Francesco Caso, et al.
Clinical Rheumatology|April 8, 2014
Efficacy of tocilizumab in a patient with refractory psoriatic arthritisLuisa Costa, Francesco Caso, Luca Cantarini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2011
Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugsMatteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 18, 2009
Detecting clinical activity in systemic lupus erythematosus with an archaeal poly(ADP-ribose) polymerase-like thermozyme: a pivotal studyMaria Rosaria Faraone-Mennella, Raffaele Scarpa, Anna Petrella, et al.
The Journal of Rheumatology|December 17, 2011
Platelet reactivity and disease activity in subjects with psoriatic arthritisMatteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, et al.
Clinical Rheumatology|May 9, 2016
Psoriatic arthritis and psoriasis: differential diagnosisMaddalena Napolitano, Francesco Caso, Raffaele Scarpa, et al.
Internal and Emergency Medicine|October 4, 2011
TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritisMatteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, et al.
Pageof 22

Showing results (21-30 of 211) with videos related to

Sort By:
Pageof 22
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2026
TOGETHER-PsA and the Case for Precision Phenotyping in Psoriatic Arthritis Commentary on: "Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults with Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial"Francesco Caso, Luisa Costa, Raffaele Scarpa, et al.
Drugs & Aging|February 21, 2014
Managing moderate-to-severe psoriasis in the elderlyNicola Balato, Cataldo Patruno, Maddalena Napolitano, et al.
The Journal of Rheumatology|September 3, 2017
Psoriatic Disease 10 Years LaterRaffaele Scarpa, Francesco Caso, Luisa Costa, et al.
International Journal of Rheumatic Diseases|March 1, 2014
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanerceptLuisa Costa, Mariangela Atteno, Francesco Caso, et al.
Clinical Rheumatology|April 8, 2014
Efficacy of tocilizumab in a patient with refractory psoriatic arthritisLuisa Costa, Francesco Caso, Luca Cantarini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2011
Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugsMatteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 18, 2009
Detecting clinical activity in systemic lupus erythematosus with an archaeal poly(ADP-ribose) polymerase-like thermozyme: a pivotal studyMaria Rosaria Faraone-Mennella, Raffaele Scarpa, Anna Petrella, et al.
The Journal of Rheumatology|December 17, 2011
Platelet reactivity and disease activity in subjects with psoriatic arthritisMatteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, et al.
Clinical Rheumatology|May 9, 2016
Psoriatic arthritis and psoriasis: differential diagnosisMaddalena Napolitano, Francesco Caso, Raffaele Scarpa, et al.
Internal and Emergency Medicine|October 4, 2011
TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritisMatteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, et al.
Pageof 22